Annual Current Liabilities
$99.87 M
-$29.67 M-22.90%
December 31, 2023
Summary
- As of February 8, 2025, AKBA annual total current liabilities is $99.87 million, with the most recent change of -$29.67 million (-22.90%) on December 31, 2023.
- During the last 3 years, AKBA annual current liabilities has fallen by -$87.28 million (-46.64%).
- AKBA annual current liabilities is now -62.41% below its all-time high of $265.69 million, reached on December 31, 2018.
Performance
AKBA Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$65.71 M
-$41.59 M-38.76%
September 30, 2024
Summary
- As of February 8, 2025, AKBA quarterly total current liabilities is $65.71 million, with the most recent change of -$41.59 million (-38.76%) on September 30, 2024.
- Over the past year, AKBA quarterly current liabilities has dropped by -$41.59 million (-38.76%).
- AKBA quarterly current liabilities is now -75.27% below its all-time high of $265.69 million, reached on December 31, 2018.
Performance
AKBA Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
AKBA Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -22.9% | -38.8% |
| 3 y3 years | -46.6% | -74.8% |
| 5 y5 years | -62.4% | -74.8% |
AKBA Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -61.7% | at low | -74.8% | at low |
| 5 y | 5-year | -61.7% | at low | -74.8% | at low |
| alltime | all time | -62.4% | +2459.5% | -75.3% | +1584.0% |
Akebia Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $65.71 M(-38.8%) |
| Jun 2024 | - | $107.30 M(+61.4%) |
| Mar 2024 | - | $66.49 M(-33.4%) |
| Dec 2023 | $99.87 M(-22.9%) | $99.87 M(+25.3%) |
| Sep 2023 | - | $79.70 M(-13.5%) |
| Jun 2023 | - | $92.18 M(+11.1%) |
| Mar 2023 | - | $82.94 M(-36.0%) |
| Dec 2022 | $129.54 M(-50.4%) | $129.54 M(-31.1%) |
| Sep 2022 | - | $187.97 M(-19.6%) |
| Jun 2022 | - | $233.68 M(-8.0%) |
| Mar 2022 | - | $253.91 M(-2.7%) |
| Dec 2021 | $261.05 M(+39.5%) | $261.05 M(+38.0%) |
| Sep 2021 | - | $189.21 M(+14.3%) |
| Jun 2021 | - | $165.59 M(-4.1%) |
| Mar 2021 | - | $172.68 M(-7.7%) |
| Dec 2020 | $187.15 M(-10.1%) | $187.15 M(+3.1%) |
| Sep 2020 | - | $181.46 M(-7.3%) |
| Jun 2020 | - | $195.77 M(-8.6%) |
| Mar 2020 | - | $214.15 M(+2.9%) |
| Dec 2019 | $208.12 M | $208.12 M(-6.7%) |
| Sep 2019 | - | $223.15 M(+20.2%) |
| Jun 2019 | - | $185.62 M(-8.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $202.61 M(-23.7%) |
| Dec 2018 | $265.69 M(+88.3%) | $265.69 M(+49.8%) |
| Sep 2018 | - | $177.40 M(+7.9%) |
| Jun 2018 | - | $164.42 M(+8.6%) |
| Mar 2018 | - | $151.42 M(+7.3%) |
| Dec 2017 | $141.11 M(+23.5%) | $141.11 M(-6.8%) |
| Sep 2017 | - | $151.36 M(-16.6%) |
| Jun 2017 | - | $181.59 M(+36.1%) |
| Mar 2017 | - | $133.46 M(+16.8%) |
| Dec 2016 | $114.27 M(+862.8%) | $114.27 M(+337.2%) |
| Sep 2016 | - | $26.14 M(+24.9%) |
| Jun 2016 | - | $20.93 M(+56.1%) |
| Mar 2016 | - | $13.41 M(+13.0%) |
| Dec 2015 | $11.87 M(+72.4%) | $11.87 M(-16.2%) |
| Sep 2015 | - | $14.17 M(+140.0%) |
| Jun 2015 | - | $5.90 M(-33.2%) |
| Mar 2015 | - | $8.84 M(+28.4%) |
| Dec 2014 | $6.88 M(+76.4%) | $6.88 M(+5.6%) |
| Sep 2014 | - | $6.52 M(+36.7%) |
| Jun 2014 | - | $4.77 M(-22.1%) |
| Mar 2014 | - | $6.12 M(+56.9%) |
| Dec 2013 | $3.90 M(-20.7%) | $3.90 M |
| Dec 2012 | $4.92 M | - |
FAQ
- What is Akebia Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Akebia Therapeutics?
- What is Akebia Therapeutics annual current liabilities year-on-year change?
- What is Akebia Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Akebia Therapeutics?
- What is Akebia Therapeutics quarterly current liabilities year-on-year change?
What is Akebia Therapeutics annual total current liabilities?
The current annual current liabilities of AKBA is $99.87 M
What is the all time high annual current liabilities for Akebia Therapeutics?
Akebia Therapeutics all-time high annual total current liabilities is $265.69 M
What is Akebia Therapeutics annual current liabilities year-on-year change?
Over the past year, AKBA annual total current liabilities has changed by -$29.67 M (-22.90%)
What is Akebia Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of AKBA is $65.71 M
What is the all time high quarterly current liabilities for Akebia Therapeutics?
Akebia Therapeutics all-time high quarterly total current liabilities is $265.69 M
What is Akebia Therapeutics quarterly current liabilities year-on-year change?
Over the past year, AKBA quarterly total current liabilities has changed by -$41.59 M (-38.76%)